Related Experiment Videos
Familial hyperproinsulinemia. An autosomal dominant defect
The New England Journal of Medicine
|April 22, 1976
Summary
A genetic defect called familial hyperproinsulinemia causes proinsulin to be the main form of circulating insulin. This autosomal dominant condition is asymptomatic and does not cause hypoglycemia or diabetes mellitus.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Proinsulin is a precursor to insulin, crucial for glucose regulation.
- Genetic mutations can lead to altered protein structure and function.
- Familial hyperproinsulinemia is a rare genetic disorder affecting insulin processing.
Purpose of the Study:
- To describe a genetic defect causing familial hyperproinsulinemia in a large kindred.
- To investigate the mode of transmission and clinical presentation of this defect.
- To elucidate the molecular basis of the observed hyperproinsulinemia.
Main Methods:
- Analysis of insulin immunoreactivity in fasting and stimulated states.
- Pedigree analysis to determine the mode of genetic transmission.
- Characterization of circulating insulin-like material.
Main Results:
- A kindred with familial hyperproinsulinemia was identified, affecting 18 individuals across four generations.
- The condition followed an autosomal dominant inheritance pattern.
- Affected individuals were asymptomatic, with no links to hypoglycemia or diabetes mellitus.
- Proinsulin or proinsulin-like material comprised the major fraction of circulating insulin immunoreactivity.
Conclusions:
- Familial hyperproinsulinemia is caused by a genetic defect leading to elevated circulating proinsulin.
- The defect is likely due to either impaired proinsulin cleavage or an abnormal proinsulin species.
- This condition highlights the importance of proper insulin processing for metabolic health.